BBSRC Portfolio Analyser
Award details
Sustainable management of aquaculture fish health through the development of low cost plant-derived vaccines
Reference
BBS/E/J/000CA596
Principal Investigator / Supervisor
Professor George Lomonossoff
Co-Investigators /
Co-Supervisors
Institution
John Innes Centre
Department
John Innes Centre Department
Funding type
Research
Value (£)
16,318
Status
Completed
Type
Institute Project
Start date
01/07/2015
End date
31/03/2017
Duration
20 months
Abstract
The aquaculture industry is the fastest growing food-producing sector worldwide. To achieve a sustainable aquaculture food-fish production and manage the aquaculture fish health, vaccination has been found to be an effective method for increasing economic output and improving animal welfare. It has also permitted the development of more sustainable fish farming with reduced use of antibiotics and chemicals. Since viral diseases pose a serious threat to aquacultures worldwide, this lack of preventive measures has extensive negative consequences. For instance, pancreas disease (PD), a viral fish disease caused by the Salmonid alphavirus (SAV) with 6 known subtypes, SAV1-6 is of significant impact on salmonid aquaculture. Another viral fish viral disease, infectious haematopoietic necrosis (IHN) which can affect most species of salmonid fish reared in fresh water or sea water, is caused by infectious haematopoietic necrosis virus. The economic loss caused by IHNV on farmed rainbow trout is a challenging task in Finnish aquaculture. Thus, there is an urgent need to develop low-cost fish vaccines to assist sustainable aquaculture production in Europe. The project aims to advance our existing plant-based recombinant protein production technologies to establish a plant-based low cost vaccine production platform to facilitate the future production of fish vaccines in large quantity at low costs. We have selected PD and IHN as two cases for proof-of-principal to test three different tobacco-production technologies (i.e. transient expression by producing virus like particles (VLPs), chloroplast genetic engineering and tobacco BY-2 cell line platform). By comparing the three systems in terms of total production costs, scaling-up potential and timeline by the end of the project period, PlantVac project can provide a technology based plant production platform for future production of PD, IHN vaccines as well as other fish vaccines.
Summary
unavailable
Committee
Not funded via Committee
Research Topics
Animal Health, Immunology
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search